Class II · ModerateActive recall
MAXIMUM
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLot #: 795CP-0005, Exp. Date 06/30/2026
Where it was soldNationwide within the U.S
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Stability Data Does Not Support Expiry Date.
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
| Distributed by / for | Dermal Source, Portland, OR 97232 |
| NDC | 80069-015 |
Show the full FDA record
| Full product label | MAXIMUM, ZONE 2, 4% Lidocaine Cream, (Lidocaine 4% and Epinephrine 0.01%), 1 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-015. |
| Recalling firm | HTO Nevada Inc. dba Kirkman |
| Distribution | Nationwide within the U.S |
| Quantity | 243 bottles |
| Recall initiated | 2026-02-18 |
| Report date | 2026-03-11 |
| Recall completed | — |
| Recall number | D-0387-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Lake Oswego OR United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.